E1	Procedure:T1 Name:T2
E3	Procedure:T3 Name:T4
E6	Age:T13 Numeric-Filter:E2
E7	Eq-Comparison:T22 Operator:T8 Value:T16 Unit:T38
E8	Eq-Comparison:T23 Operator:T9 Value:T17 Unit:T43
E9	Eq-Comparison:T24 Operator:T10 Temporal-Unit:T12 Value:T21
E2	Eq-Comparison:T25 Operator:T26 Value:T14 Value2:T15 Temporal-Unit:T11
E4	Condition:T27 Name:T28 Polarity:T30
E11	Modifier:T31 Modifies:T28
E12	Procedure:T32 Name:T33
E13	Observation:T34 Name:T35 Numeric-Filter:E7
E14	Observation:T36 Name:T37
E15	Observation:T39 Name:T40 Numeric-Filter:E8
E16	Observation:T41 Name:T42
E17	Condition:T44 Name:T45
E18	Condition:T46 Name:T47 Polarity:T49
E20	Observation:T50 Name:T51 Numeric-Filter:E21
E21	Eq-Comparison:T52 Value:T18 Value2:T19 Value3:T20
E22	Condition:T53 Name:T54 Polarity:T55
E23	Eq-Comparison:T7 Operator:T59 Unit:T56 Value:T57 Value2:T58
E24	Procedure:T60 Name:T61
E25	Assertion:T62 Asserted:E24
E27	Modifier:T64 Modifies:E24
E5	Observation:T5 Name:T6 Temporality:E9
E29	Modifier:T66 
E30	Modifier:T67 
E32	Study:T69 
E34	Negation:T71 Negates:E1
E36	Negation:T73 Negates:E1
E37	Assertion:T74 Asserted:E34
E38	Assertion:T75 Asserted:E36
T1	Procedure 473 492	genetic counselling
T2	Procedure-Name 473 492	genetic counselling
T3	Procedure 326 337	neoadjuvant
T4	Procedure-Name 326 337	neoadjuvant
T8	Eq-Operator 171 172	<
T9	Eq-Operator 206 207	<
T10	Eq-Operator 386 392	within
T11	Eq-Temporal-Unit 47 52	years
T12	Eq-Temporal-Unit 395 401	months
T13	Age 25 28	age
T14	Eq-Value 37 39	18
T15	Eq-Value 44 46	60
T16	Eq-Value 173 174	1
T17	Eq-Value 208 209	1
T18	Eq-Value 235 236	0
T19	Eq-Value 238 239	1
T20	Eq-Value 244 245	2
T21	Eq-Value 393 394	6
T22	Eq-Comparison 171 175	< 1%
T23	Eq-Comparison 206 210	< 1%
T24	Eq-Comparison 386 401	within 6 months
T25	Eq-Comparison 29 52	between 18 and 60 years
T26	Eq-Operator 29 36	between
T27	Condition 132 145	breast cancer
T28	Condition-Name 132 145	breast cancer
T30	Polarity 123 131	negative
T31	Modifier 116 122	triple
T32	Procedure 91 105	histologically
T33	Procedure-Name 91 105	histologically
T34	Observation 151 169	Estrogen Receptors
T35	Observation-Name 151 169	Estrogen Receptors
T36	Observation 147 149	ER
T37	Observation-Name 147 149	ER
T38	Eq-Unit 174 175	%
T39	Observation 182 204	Progesterone Receptors
T40	Observation-Name 182 204	Progesterone Receptors
T41	Observation 177 180	PgR
T42	Observation-Name 177 180	PgR
T43	Eq-Unit 209 210	%
T44	Condition 212 216	HER2
T45	Condition-Name 212 216	HER2
T46	Condition 217 220	neu
T47	Condition-Name 217 220	neu
T49	Polarity 221 229	negative
T50	Observation 231 234	IHC
T51	Observation-Name 231 234	IHC
T52	Eq-Comparison 235 246	0, 1+ or 2+
T53	Condition 247 251	FISH
T54	Condition-Name 247 251	FISH
T55	Polarity 252 260	negative
T7	Eq-Comparison 268 279	Stage I-III
T56	Eq-Unit 268 273	Stage
T57	Eq-Value 274 275	I
T58	Eq-Value 276 279	III
T59	Eq-Operator 275 276	-
T60	Procedure 301 308	surgery
T61	Procedure-Name 301 308	surgery
T62	Assertion 285 292	Able to
T64	Modifier 310 317	primary
T5	Observation 377 385	material
T6	Observation-Name 377 385	material
T66	Modifier 369 376	bioptic
T67	Modifier 360 368	surgical
T69	Study 407 416	enrolment
T71	Negation 452 461	unwilling
T73	Negation 442 448	unable
T74	Assertion 452 461	unwilling
T75	Assertion 442 448	unable
A1	Eq-Operator-Value T8 LT
A2	Eq-Operator-Value T9 LT
A3	Eq-Operator-Value T10 LTEQ
A4	Eq-Temporal-Unit-Value T11 year
A5	Eq-Temporal-Unit-Value T12 month
A6	Eq-Operator-Value T26 BETWEEN
A7	Polarity-Value T30 negative
A8	Observation-Type-Value E13 lab
A9	Observation-Type-Value E15 lab
A10	Polarity-Value T49 negative
A11	Polarity-Value T55 negative
A12	Eq-Operator-Value T59 BETWEEN
A13	Assertion-Type-Value E25 hypothetical
A16	Assertion-Type-Value E37 hypothetical
A17	Assertion-Type-Value E38 hypothetical
R1	Found-By Arg1:E4 Arg2:E12
R2	Abbrev-Of Arg1:E14 Arg2:E13
R3	Abbrev-Of Arg1:E16 Arg2:E15
R5	Equivalent-To Arg1:E20 Arg2:E18
R6	Or Arg1:E17 Arg2:E18
R7	After Arg1:E24 Arg2:E3
R9	Or Arg1:E30 Arg2:E29
R10	After Arg1:E9 Arg2:E32
R11	Or Arg1:E36 Arg2:E34
R8	Or Arg1:E27 Arg2:E3	
R4	Equivalent-To Arg1:E22 Arg2:E18	
